RSV Bivalent Prefusion F Protein Vaccine in Pregnancy and Protection Against RSV-Associated Illness in Infants: A Systematic Review and Meta-Analysis.
This systematic review and meta-analysis assessed real-world effectiveness of maternal RSV bivalent prefusion F protein vaccination in preventing RSV-associated lower respiratory tract infection (LRTI) hospitalization…
Why it matters
RSV-associated LRTI hospitalization is an important early-life outcome, and these real-world findings indicate that maternal RSVpreF vaccination is associated with substantial protection across the first 6 months.